Best Pharmaceuticals for Children Amendments of 2007
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 3,722 other S bills in the 110th — cohort avg 42d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (6)
2008 · fourth_quarter · Pharmacy
Bills with similar content found using semantic analysis.
Sources: Congress.gov
-H.R. 2589, "Improving Pharmaceuticals for Children Act of 2007," regarding amending the Federal Food, Drug, and Cosmetics Act and the Public Health Service Act to reauthorize and amend the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act. -S. 1156, Best Pharmaceuticals for Children Amendments of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act to reauthorize the Best Pharmaceuticals for Children program; -S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs; -S. 251, Pharmaceutical Market Access Act of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs; -H.R. 4083 / S. 2311, "Non-Prescription Drug Modernization Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act to provide for the amendment or repeal of monographs, to expand the Food and Drug Administration's authority to regulate drug advertising, and for other purposes; -S. 1951, "Fair Medicaid Drug Payment Act of 2007," regarding amending title XIX of the Social Security Act to ensure that individuals eligible for medical assistance under the Medicaid program continue to have access to prescription drugs, and for other purposes.
Client expense: $1,440,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2008 · fourth_quarter · Pharmacy
-H.R. 2589, "Improving Pharmaceuticals for Children Act of 2007," regarding amending the Federal Food, Drug, and Cosmetics Act and the Public Health Service Act to reauthorize and amend the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act. -S. 1156, Best Pharmaceuticals for Children Amendments of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act to reauthorize the Best Pharmaceuticals for Children program; -S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs; -S. 251, Pharmaceutical Market Access Act of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs; -H.R. 4083 / S. 2311, "Non-Prescription Drug Modernization Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act to provide for the amendment or repeal of monographs, to expand the Food and Drug Administration's authority to regulate drug advertising, and for other purposes; -S. 1951, "Fair Medicaid Drug Payment Act of 2007," regarding amending title XIX of the Social Security Act to ensure that individuals eligible for medical assistance under the Medicaid program continue to have access to prescription drugs, and for other purposes.
Client expense: $1,440,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2008 · fourth_quarter · Pharmacy
-H.R. 2589, "Improving Pharmaceuticals for Children Act of 2007," regarding amending the Federal Food, Drug, and Cosmetics Act and the Public Health Service Act to reauthorize and amend the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act. -S. 1156, Best Pharmaceuticals for Children Amendments of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act to reauthorize the Best Pharmaceuticals for Children program; -S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs; -S. 251, Pharmaceutical Market Access Act of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs; -H.R. 4083 / S. 2311, "Non-Prescription Drug Modernization Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act to provide for the amendment or repeal of monographs, to expand the Food and Drug Administration's authority to regulate drug advertising, and for other purposes; -S. 1951, "Fair Medicaid Drug Payment Act of 2007," regarding amending title XIX of the Social Security Act to ensure that individuals eligible for medical assistance under the Medicaid program continue to have access to prescription drugs, and for other purposes.
Client expense: $1,440,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2008 · third_quarter · Pharmacy
-H.R. 2589, "Improving Pharmaceuticals for Children Act of 2007," regarding amending the Federal Food, Drug, and Cosmetics Act and the Public Health Service Act to reauthorize and amend the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act. -S. 1156, Best Pharmaceuticals for Children Amendments of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act to reauthorize the Best Pharmaceuticals for Children program; -S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs; -S. 251, Pharmaceutical Market Access Act of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs; -H.R. 4083 / S. 2311, "Non-Prescription Drug Modernization Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act to provide for the amendment or repeal of monographs, to expand the Food and Drug Administration's authority to regulate drug advertising, and for other purposes; -S. 1951, "Fair Medicaid Drug Payment Act of 2007," regarding amending title XIX of the Social Security Act to ensure that individuals eligible for medical assistance under the Medicaid program continue to have access to prescription drugs, and for other purposes.
Client expense: $1,500,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2008 · second_quarter · Pharmacy
H.R. 2589, "Improving Pharmaceuticals for Children Act of 2007," regarding amending the Federal Food, Drug, and Cosmetics Act and the Public Health Service Act to reauthorize and amend the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act. S 1156, Best Pharmaceuticals for Children Amendments of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act to reauthorize the Best Pharmaceuticals for Children program; S 242, Pharmaceutical Market Access and Drug Safety Act of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs; S 251, Pharmaceutical Market Access Act of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs; HR 4083 / S 2311, "Non-Prescription Drug Modernization Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act to provide for the amendment or repeal of mongraphs, to expand the Food and Drug Administration's authority to regulate drug advertising, and for other purposes; S 1951, "Fair Medicaid Drug Payment Act of 2007," regarding amending title XIX of the Social Security Act to ensure that individuals eligible for medical assistance under the Medicaid program continue to have access to prescription drugs, and for other purposes.
Client expense: $1,700,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2008 · first_quarter · Pharmacy
H.R. 2589, "Improving Pharmaceuticals for Children Act of 2007," regarding amending the Federal Food, Drug, and Cosmetics Act and the Public Health Service Act to reauthorize and amend the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act; S 1156, Best Pharmaceuticals for Children Amendments of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act to reauthorize the Best Pharmaceuticals for Children program; S 242, Pharmaceutical Market Access and Drug Safety Act of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs; S 251, Pharmaceutical Market Access Act of 2007, regarding amending the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs; HR 4083 / S 2311, "Non-Prescription Drug Modernization Act of 2007," regarding amending the Federal Food, Drug, and Cosmetic Act to provide for the amendment or repeal of mongraphs, to expand the Food and Drug Administration's authority to regulate drug advertising, and for other purposes; S 1951, "Fair Medicaid Drug Payment Act of 2007," regarding amending title XIX of the Social Security Act to ensure that individuals eligible for medical assistance under the Medicaid program continue to have access to prescription drugs, and for other purposes.
Client expense: $1,440,000 · Firm income: Not reported
2007 · year_end · Health Issues
H.R. 2723, S. 1226, "Children's Health Care Quality Act," all provisions. H.R. 1308, S. 764, "Legal Immigrant Children's Health Improvement Act," all provisions. S. 1156, "Best Pharamaceuticals For Children Amendments of 2007," all provisions. H.R. 2589, "Imporving Pharamecuticals for Children Act of 2007," all provisions. S. 993, "Pediatric Research Improvement Act," all provisions. H.R. 1494, S. 830, "Pediatric Medical Device Safety and Improvement Act of 2007," all provisions. S. 1082, "Food and Drug Administration Revitalization Act," provisions relating to pharmaceutical and medical device testing for children. H.R. 2900, "Food and Drug Administration Amendments Act of 2007," provisions relating to pharmaceutical and medical device testing for children S. 1970, Addressing the Disaster Needs of Children Act, all provisions. S. 911/H.R. 1553, Conquer Childhood Cancer Act, all provisions. H.R. 4450, Pediatric, Adolescent, and Young Adult Cancer Survivorship Research and Quality of Life Act, all provisions.
Client expense: $834,165 · Firm income: Not reported
2007 · year_end · Pharmacy
H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA, drug safety provisions H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics H. R. 2638, Homeland Security Appropriations Act, drug importation provisions H. R. 2764, Foreign Operations and Related Programs Appropriations Act, 2008 H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions H. R. 3043, Labor-HHS-Education and Related Agencies Appropriations Act, diabetes research funding H. R. 3580, Food and Drug Administration Amendments Act of 2007 S. 1024, Safer DATA Act, clinical trials/drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1644, Homeland Security Appropriations Act, drug importation provisions S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 1710, Labor-HHS-Education and Related Agencies Appropriations Act, diabetes research funding S. 1745, Commerce, Justice, Science and Related Agencies Appropriations Act, DEA drug importation language S. 2029, Physician Payments Sunshine Act of 2007 S. 467, FACT Act, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions S. 1156, Best Pharmaceuticals for Children Amendments of 2007, pediatric exclusivity provisions in FDARA/PDUFA bill S. 623, Access to Life-Saving Medicine Act, follow-on biologics
2007 · year_end · Pharmacy
H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions H. R. 3580, Food and Drug Administration Amendments Act of 2007 S. 1024, Safer DATA Act, clinical trials/drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions S. 1156, Best Pharmaceuticals for Children Amendments of 2007, pediatric exclusivity provisions in FDARA/PDUFA bill S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions S. 4, Improving America's Security Act of 2007, cargo-screening provision S. 467, FACT Act, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions H. R. 1, Implementing the 9/11 Commission Recommendations Act of 2007, cargo-screening provision H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA, drug safety provisions
Client expense: Not reported · Firm income: $80,000
2007 · year_end · Pharmacy
H. R. 2638, Homeland Security Appropriations Act, drug importation provisions H. R. 2764, Foreign Operations and Related Programs Appropriations Act, 2008, (Division A, Division G) H. R. 2900, Food and Drug Administration Revitalization Act, drug safety provisions H. R. 3093, Departments of Commerce and Justice, Science, and Related Agencies Appropriations Act, DEA drug importation language H.R. 3043, Labor, Heath/Human Services/Education/Related Agencies Appropriations Act, 2008 H.R. 3580, Food and Drug Administration Amendments Act of 2007 S. 1024, Safer DATA Act, clinical trials/drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, drug safety provisions S. 1156, Best Pharmaceuticals for Children Amendments of 2007, pediatric exclusivity provisions in FDARA/PDUFA bill S. 1505, Affordable Biologics for Consumers Act, follow-on biologics S. 1644, Homeland Security Appropriations Act, drug importation provisions S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 1710, Labor, Heath/Human Services/Education/Related Agencies Appropriations Act, 2008 S. 1745, Departments of Commerce and Justice, Science, and Related Agencies Appropriations Act, DEA drug importation language S. 2029, Physician Payments Sunshine Act of 2007 S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions S. 467, FACT Act, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, drug safety provisions H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics
2007 · year_end · Pharmacy
H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA/drug safety H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics H. R. 2638, Homeland Security Appropriations Act, drug importation provisions H. R. 2764, Foreign Operations and Related Programs Appropriations Act, 2008, (Division A & G) H. R. 2900, Food and Drug Administration Revitalization Act, PDUFA/drug safety H. R. 3043, Labor-HHS-Education and Related Agencies Appropriations Act, Medicare, healthcare, and drug pricing provisions H. R. 3580, Food and Drug Administration Amendments Act of 2007 S. 1024, Safer DATA Act, clinical trials/drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA/drug safety S. 1156, Best Pharmaceuticals for Children Amendmentsk, pediatric exclusivity provisions in FDARA/PDUFA bill S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1644, Homeland Security Appropriations Act, drug importation provisions S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 1710, Labor-HHS-Education and Related Agencies Appropriations Act, Medicare, healthcare, and drug pricing provisions S. 2029, Physician Payments Sunshine Act of 2007 S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions H. R. 1585, National Defense Authorization Act, drug pricing provisions S. 1547, National Defense Authorization Act, drug pricing provisions S. 467, FACT Act, clinical trials/drug safety provisions
2007 · year_end · Pharmacy
H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA and drug safety H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics H. R. 2764, Foreign Operations and Related Programs Appropriations Act, 2008, (Division A & G) H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA and drug safety H. R. 3043, Labor-HHS-Education and Related Agencies Appropriations Act, Medic H. R. 3580, Food and Drug Administration Amendments Act of 2007 S. 1024, Safer DATA Act, clinical trials and drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA and drug safety S. 1156, Best Pharmaceuticals for Children Amendments of 2007, pediatric exclusivity provisions in FDARA/PDUFA bill S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1644, Homeland Security Appropriations Act, drug importation provisions S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 1710, Labor-HHS-Education and Related Agencies Appropriations Act, Medicare, healthcare, and drug pricing provisions S. 2029, Physician Payments Sunshine Act of 2007 S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions S. 467, FACT Act, clinical trials and drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials and drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials and drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics S. 993, Pediatric Research Improvement Act, clinical trials and drug safety provisions S. 1745, Commerce, Justice, Science, and Related Agencies Appropriations Act, DEA drug importation language H. R. 2638, Homeland Security Appropriations Act, drug importation provisions
2007 · mid_year · Pharmacy
S 242, “Pharmaceutical Market Access and Drug Safety Act of 2007,” regarding amending the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs; S 251, “Pharmaceutical Market Access Act of 2007,” regarding amending the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs. HR 2589, “Improving Pharmaceuticals for Children Act of 2007,” regarding amending the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act to reauthorize and amend the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act; S 1156, “Best Pharmaceuticals for Children Amendments of 2007,” regarding amending the Federal Food, Drug, and Cosmetic Act to reauthorize the Best Pharmaceuticals for Children program;
Client expense: $3,820,000 · Firm income: Not reported
2007 · mid_year · Pharmacy
H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA, drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions S. 467, FACT Act, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 1024, Safer DATA Act, clinical trials/drug safety provisions H. Con. Res. 99, Budget Resolution, drug importation, comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation, comparative effectiveness provisions S. 1745, Commerce, Justice, Science and Related Agencies Appropriations Act, DEA drug importation language H. R. 2638, Homeland Security Appropriations Act, drug importation provisions S. 1644, Homeland Security Appropriations Act, drug importation provisions S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions S. 1156, Best Pharmaceuticals for Children Amendments of 2007, pediatric exclusivity provisions in FDARA/PDUFA bill S. 623, Access to Life-Saving Medicine Act, follow-on biologics
Client expense: Not reported · Firm income: $100,000
2007 · mid_year · Pharmacy
H.R. 2900, FDA Amendments Act of 2007, PDUFA S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA H.R. 1561, Enhancing Drug Safety and Innovation Act, PDUFA S. 1156, Best Pharmaceutical for Children Amendments of 2007, pediatric provisions
Client expense: $300,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE
2007 · mid_year · Pharmacy
S. 1644, Homeland Security Appropriations Act, drug importation provisions H. Con. Res. 99, Budget Resolution, drug importation and comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation and comparative effectiveness provisions S. 467, FACT Act, clinical trials and drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials and drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials and drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials and drug safety provisions S. 1024, Safer DATA Act, clinical trials and drug safety provisions H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA and drug safety S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA and drug safety H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA and drug safety S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 1156, Best Pharmaceuticals for Children Amendments of 2007, pediatric exclusivity provisions in FDARA/PDUFA bill S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions S. 1745, Commerce, Justice, Science, and Related Agencies Appropriations Act, DEA drug importation language H. R. 2638, Homeland Security Appropriations Act, drug importation provisions
Client expense: Not reported · Firm income: $100,000
2007 · mid_year · Pharmacy
S. 4, Improving America's Security Act of 2007, cargo-screening provision S. 467, FACT Act, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 1024, Safer DATA Act, clinical trials/drug safety provisions H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA, drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 1156, Best Pharmaceuticals for Children Amendments of 2007, pediatric exclusivity provisions in FDARA/PDUFA bill S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions H. Con. Res. 99, Budget Resolution, drug importation and comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation and comparative effectiveness provisions H. R. 1, Implementing the 9/11 Commission Recommendations Act of 2007, cargo-screening provision
Client expense: Not reported · Firm income: $80,000
2007 · mid_year · Pharmacy
H. R. 3093, Departments of Commerce and Justice, Science, and Related Agencies Appropriations Act, DEA drug importation language H. R. 2642, Military Construction-VA and related Agencies Appropriations Act, diabetes care provisions S. 1645, Military Construction-VA and related Agencies Appropriations Act, diabetes care provisions H. Con. Res. 99, Budget Resolution, drug importation provisions S. Con. Res. 21, Budget Resolution, drug importation provisions S. 467, FACT Act, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 1024, Safer DATA Act, clinical trials/drug safety provisions H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, drug safety provisions H. R. 2900, Food and Drug Administration Revitalization Act, drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 1156, Best Pharmaceuticals for Children Amendments of 2007, pediatric exclusivity provisions in FDARA/PDUFA bill S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions S. 1745, Departments of Commerce and Justice, Science, and Related Agencies Appropriations Act, DEA drug importation language H. R. 2638, Homeland Security Appropriations Act, drug importation provisions S. 1644, Homeland Security Appropriations Act, drug importation provisions
2007 · mid_year · Pharmacy
S. 1644 Homeland Security Appropriations Act, drug importion provisions H.Con Res. 99 Budget Resolution, drug importation and comparative effectiveness provisions S. Con. Res 21 Budget Resolution, drug imporatation and comparative effectiveness provisions S. 467, FACT Act, clinical trials and drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials and drug safety provisions S. 484, Enhancing Drug safety and Innovation Act of 2007, clinical trials and drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials and drug safety provisions S. 1024, Safe DATA Act, clinical trials and drug safety provisions HR 1561, Enhancing Drug safety and Innovation Act of 2007, PDUFA and Drug Safety S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA and drug safety HR 2900, Food and Drug Administration Amendments Act of 2007, PDUFA and drug safety S. 623, Access to Life-Saving Medicine Act, Follow-on Biologics HR 1038, Access to Life Saving Medicine Act, follow-on Biologics HR 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, Follow-on Biologics S. 1505, Affordable Biologics for Consumers Act of 2007, Follow-on Biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, Follow-on Biologics S. 1156, Best Pharmaceuticals for Children Amendments of 2007, pediatric exclusivity provisions in FDARA / PDUFA Bill S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions S. 1745 Commerce, Justice, Science, and Related Agencies Appropriations Act, DEA Drug importation language HR 2638, Homeland Security Appropriations Act, Drug Importation Provisions Product approval discussions with Deputy Director, Food and Drug Administration
Client expense: $920,000 · Firm income: Not reported
2007 · mid_year · Health Issues
S. 1156, “Best Pharmaceuticals For Children Amendments of 2007,” all provisions. H.R. 2589, “Improving Pharmaceuticals for Children Act of 2007,” all provisions. S. 993, “Pediatric Research Improvement Act,” all provisions. H.R. 1494, S. 830, “Pediatric Medical Device Safety and Improvement Act of 2007,” all provisions. S. 1082, “Food and Drug Administration Revitalization Act,” provisions relating to pharmaceutical and medical device testing for children. H.R. 2900, “Food and Drug Administration Amendments Act of 2007,” provisions relating to pharmaceutical and medical device testing for children. H.R. 2723, S. 1226, “Children’s Health Care Quality Act,” all provisions. H.R. 1308, S. 764, “Legal Immigrant Children’s Health Improvement Act,” all provisions.
Client expense: $1,234,877 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2007 · mid_year · Pharmacy
S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 1024, Safer DATA Act, clinical trials/drug safety provisions H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA/drug safety S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA/drug safety H. R. 2900, Food and Drug Administration Revitalization Act, PDUFA/drug safety S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 1156, Best Pharmaceuticals for Children Amendmentsk, pediatric exclusivity provisions in FDARA/PDUFA bill S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions H. R. 1585, National Defense Authorization Act, drug pricing provisions S. 1547, National Defense Authorization Act, drug pricing provisions S. 467, FACT Act, clinical trials/drug safety provisions
Client expense: Not reported · Firm income: $40,000
2007 · mid_year · Health Issues
Appropriate Physician payment levels/systems Medical Records Confidentiality Deficit Reduction Act Children's access to health insurance Immunizations WIC national Immunizations program (administration) The Start Healthy, Stay Healthy Act Medikids Health Insurance Act of 2007 Ephedrine Alkaloid Consumer Protection Act Immunization Coding Issues Paul Wellstone Mental Health and Addiction Equity Act (HR 1424) Health Care Coverage Expansion and Quality Improvement Act Children's Access to Vision Improvement Act Pandemic Influenza Health Information Technology/Electronic Health Records Emergency Medical Services for Children Act Reauthorization Injury Prevention Best Pharmaceuticals for Children Act (HR 2589) Pediatric Research Equity Act (S.993) Children and Families HIV/AIDS Care and Research Act Pediatric Medical Device Safety and Improvement Act of 2007 (HR 1494/S. 830) Ryan White CARE Act Child Health Care Crisis Relief Act Enhancing Drug Safety and Innovation Act Mental Health Parity Lower PRICED Drugs Preemie Act Pediatrics Disaster Preparedness Education Begins at Home Act Child Maltreatment Foster Care and Adoption Native American Child Health Genetic Nondiscrimination Reauthorization of SCHIP S. 588 Resident Physician Shortage Reduction Act HR 3/S. 5 Stem Cell Research Enhancement Act HR 881 Mercury Free Vaccines Act HR 2184 Enhanced Health Care Value For All Act HR 2584 High Heed Physician Workforce Incentives Act S. 1576 Minority Health Improvement and Health Disparity Elimination Act HR 1153 Parental Right to Decide Protection Act Access to Life-Saving Medicine Act Biologics Price Competition and Innovation Act of 2007 Food and Drug Administration Revitalization Act S. 1082 Food and Drug Administration Amendments Act of 2007 HR 2900 Improving Pharmaceuticals for Children Act of 2007 HR 2589 Best Pharmaceuticals for Children Amendments of 2007 S. 1156 Pediatric Research Improvement Act S. 993 School-Based Health Clinics Establishment Act Early Hearing and Detection and Intervention Family Smoking Prevention and Tobacco Control Act Prescription Drug User Fee Act FACT Act State Children's Health Insurance Program (SCHIP) Managed Care Reform
2007 · mid_year · Medical/Disease Research/Clinical Labs
Stem Cell Research Enhancement Act of 2005 HR 3/S.5 Clinical Trials Registry National Children's Study Preservation of Antibiotics of Medical Treatment Act Pediatric Medical Device Study and Improvement Act of 2007 HR 1424/S. 830 Ryan White CARE Act Patient Safety and Quality Improvement Act Best Pharmaceuticals for Children Act Preemie Act HR 2184 Enhanced Health Care Value For All Act S. 1576 Minority Health Improvement and Health Disparity Elimination Act Pediatric Research Equity Act Access to Life-Saving Medicine Act Biologics Price Competition and Innovation Act of 2007 Food and Drug Administration Revitalization Act S. 1082 Food and Drug Administration Amendments Act of 2007 HR 2900 Improving Pharmaceuticals for Children Act of 2007 HR 2589 Best Pharmaceuticals for Children Amendments of 2007 S. 1156 Pediatric Research Improvement Act S. 993 School-Based Health Clinics Establishment Act Early Hearing and Detection and Intervention Family Smoking Prevention and Tobacco Control Act Prescription Drug User Fee Act FACT Act
Client expense: $160,000 · Firm income: Not reported
| Democratic |
| NM |
| Patty Murray | Democratic | WA |
| Sherrod Brown | Democratic | OH |
| Tom Harkin | Democratic | IA |
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, UNDETERMINED, White House Office
Client expense: Not reported · Firm income: $120,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Client expense: Not reported · Firm income: $80,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Client expense: Not reported · Firm income: $20,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
Client expense: Not reported · Firm income: $100,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE
Client expense: Not reported · Firm income: $40,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
Client expense: $160,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Consumer Product Safety Commission (CPSC), Environmental Protection Agency (EPA), Federal Communications Commission (FCC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Homeland Security, Dept of (DHS), Indian Health Service, Labor, Dept of (DOL), Natl Transportation Safety Board (NTSB), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, White House Office
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Consumer Product Safety Commission (CPSC), Environmental Protection Agency (EPA), Federal Communications Commission (FCC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Homeland Security, Dept of (DHS), Indian Health Service, Labor, Dept of (DOL), Natl Transportation Safety Board (NTSB), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, White House Office